Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Peter Borchmann, MD"'
Autor:
Michael Oertel, MD, Dominik Hering, MSc, Nina Nacke, MSc, Christopher Kittel, MSc, Kai Kröger, MD, Jan Kriz, MD, Michael Fuchs, MD, Christian Baues, MD, Dirk Vordermark, MD, Rita Engenhart-Cabillic, MD, Klaus Herfarth, MD, Peter Lukas, MD, Heinz Schmidberger, MD, Simone Marnitz, MD, Peter Borchmann, MD, Andreas Engert, MD, Uwe Haverkamp, Hans Theodor Eich, MD
Publikováno v:
Advances in Radiation Oncology, Vol 8, Iss 3, Pp 101169- (2023)
Purpose: Radiation therapy (RT) is an integral part of treatment concepts for early-stage Hodgkin lymphoma. This analysis reports on RT quality in the recent HD16 and 17 trials of the German Hodgkin Study Group (GHSG). Methods and Materials: All RT p
Externí odkaz:
https://doaj.org/article/be482eea6f1c4df195be317ffeda2c0d
Publikováno v:
Business Wire (English). 06/01/2024.
Autor:
Diehl, Volker
This issue of Hematology/Oncology Clinics is focused on Hodgkin's Lymphoma and covers such topics as First HRS-cell line L428 and the detection of the CD-30 Antigen, “Normal“ CD30-B-lymphocytes, CD-30-Antigen, Combination-Chemo-Radiotherapy, Earl
Autor:
Burstein, Harold J.
This issue, focusing on Breast Cancer, includes topics such as: Radiation Therapy for DCIS, Axillary dissection, Pathology in the age of personalized breast cancer treatment:, Clinical implications for breast cancer subsets defined by molecular diagn
Autor:
Sweeney, Christopher J.
This issue of Hematology/Oncology Clinics is focused on Prostate Cancer and highlights topics such as: Prevention, Early Detection, Biomarkers, Risk stratification, Imaging in Prostate Cancer, Adjuvant hormonal therapy, Management of patient with bio
Autor:
Wagner, Andrew J.
This issue focuses on Sarcoma in areas such as: Gastrointestinal Stromal Tumors: Risk assessment and adjuvant therapy, Gastrointestinal Stromal Tumors: Management of metastatic disease and emerging therapies, Liposarcoma, Leiomyosarcoma, Update in tr
Autor:
Fuchs M; Michael Fuchs, MD and Helen Goergen, Dipl-Math, German Hodgkin Study Group, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany; Carsten Kobe, MD, Department of Nuclear Medicine, University of Cologne, Cologne, Germany; and Peter Borchmann, MD, PhD and Andreas Engert, MD, German Hodgkin Study Group, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany., Goergen H; Michael Fuchs, MD and Helen Goergen, Dipl-Math, German Hodgkin Study Group, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany; Carsten Kobe, MD, Department of Nuclear Medicine, University of Cologne, Cologne, Germany; and Peter Borchmann, MD, PhD and Andreas Engert, MD, German Hodgkin Study Group, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany., Kobe C; Michael Fuchs, MD and Helen Goergen, Dipl-Math, German Hodgkin Study Group, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany; Carsten Kobe, MD, Department of Nuclear Medicine, University of Cologne, Cologne, Germany; and Peter Borchmann, MD, PhD and Andreas Engert, MD, German Hodgkin Study Group, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany., Borchmann P; Michael Fuchs, MD and Helen Goergen, Dipl-Math, German Hodgkin Study Group, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany; Carsten Kobe, MD, Department of Nuclear Medicine, University of Cologne, Cologne, Germany; and Peter Borchmann, MD, PhD and Andreas Engert, MD, German Hodgkin Study Group, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany., Engert A; Michael Fuchs, MD and Helen Goergen, Dipl-Math, German Hodgkin Study Group, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany; Carsten Kobe, MD, Department of Nuclear Medicine, University of Cologne, Cologne, Germany; and Peter Borchmann, MD, PhD and Andreas Engert, MD, German Hodgkin Study Group, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2020 Apr 01; Vol. 38 (10), pp. 1116-1117. Date of Electronic Publication: 2020 Jan 30.
Autor:
Kobe C; Carsten Kobe, MD, University Hospital of Cologne, University of Cologne, Cologne, Germany; Helen Goergen, Dipl-Math, Michael Fuchs, MD, and Horst Müller, German Hodgkin Study Group, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany; Christan Baues, MD, University Hospital of Cologne, University of Cologne, Cologne, Germany; Andreas Engert, MD, German Hodgkin Study Group, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany; Markus Dietlein, MD, University Hospital of Cologne, University of Cologne, Cologne, Germany; and Bastian von Tresckow, MD and Peter Borchmann, MD, German Hodgkin Study Group, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany., Goergen H; Carsten Kobe, MD, University Hospital of Cologne, University of Cologne, Cologne, Germany; Helen Goergen, Dipl-Math, Michael Fuchs, MD, and Horst Müller, German Hodgkin Study Group, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany; Christan Baues, MD, University Hospital of Cologne, University of Cologne, Cologne, Germany; Andreas Engert, MD, German Hodgkin Study Group, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany; Markus Dietlein, MD, University Hospital of Cologne, University of Cologne, Cologne, Germany; and Bastian von Tresckow, MD and Peter Borchmann, MD, German Hodgkin Study Group, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany., Fuchs M; Carsten Kobe, MD, University Hospital of Cologne, University of Cologne, Cologne, Germany; Helen Goergen, Dipl-Math, Michael Fuchs, MD, and Horst Müller, German Hodgkin Study Group, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany; Christan Baues, MD, University Hospital of Cologne, University of Cologne, Cologne, Germany; Andreas Engert, MD, German Hodgkin Study Group, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany; Markus Dietlein, MD, University Hospital of Cologne, University of Cologne, Cologne, Germany; and Bastian von Tresckow, MD and Peter Borchmann, MD, German Hodgkin Study Group, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany., Müller H; Carsten Kobe, MD, University Hospital of Cologne, University of Cologne, Cologne, Germany; Helen Goergen, Dipl-Math, Michael Fuchs, MD, and Horst Müller, German Hodgkin Study Group, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany; Christan Baues, MD, University Hospital of Cologne, University of Cologne, Cologne, Germany; Andreas Engert, MD, German Hodgkin Study Group, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany; Markus Dietlein, MD, University Hospital of Cologne, University of Cologne, Cologne, Germany; and Bastian von Tresckow, MD and Peter Borchmann, MD, German Hodgkin Study Group, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany., Baues C; Carsten Kobe, MD, University Hospital of Cologne, University of Cologne, Cologne, Germany; Helen Goergen, Dipl-Math, Michael Fuchs, MD, and Horst Müller, German Hodgkin Study Group, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany; Christan Baues, MD, University Hospital of Cologne, University of Cologne, Cologne, Germany; Andreas Engert, MD, German Hodgkin Study Group, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany; Markus Dietlein, MD, University Hospital of Cologne, University of Cologne, Cologne, Germany; and Bastian von Tresckow, MD and Peter Borchmann, MD, German Hodgkin Study Group, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany., Engert A; Carsten Kobe, MD, University Hospital of Cologne, University of Cologne, Cologne, Germany; Helen Goergen, Dipl-Math, Michael Fuchs, MD, and Horst Müller, German Hodgkin Study Group, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany; Christan Baues, MD, University Hospital of Cologne, University of Cologne, Cologne, Germany; Andreas Engert, MD, German Hodgkin Study Group, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany; Markus Dietlein, MD, University Hospital of Cologne, University of Cologne, Cologne, Germany; and Bastian von Tresckow, MD and Peter Borchmann, MD, German Hodgkin Study Group, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany., Dietlein M; Carsten Kobe, MD, University Hospital of Cologne, University of Cologne, Cologne, Germany; Helen Goergen, Dipl-Math, Michael Fuchs, MD, and Horst Müller, German Hodgkin Study Group, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany; Christan Baues, MD, University Hospital of Cologne, University of Cologne, Cologne, Germany; Andreas Engert, MD, German Hodgkin Study Group, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany; Markus Dietlein, MD, University Hospital of Cologne, University of Cologne, Cologne, Germany; and Bastian von Tresckow, MD and Peter Borchmann, MD, German Hodgkin Study Group, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany., von Tresckow B; Carsten Kobe, MD, University Hospital of Cologne, University of Cologne, Cologne, Germany; Helen Goergen, Dipl-Math, Michael Fuchs, MD, and Horst Müller, German Hodgkin Study Group, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany; Christan Baues, MD, University Hospital of Cologne, University of Cologne, Cologne, Germany; Andreas Engert, MD, German Hodgkin Study Group, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany; Markus Dietlein, MD, University Hospital of Cologne, University of Cologne, Cologne, Germany; and Bastian von Tresckow, MD and Peter Borchmann, MD, German Hodgkin Study Group, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany., Borchmann P; Carsten Kobe, MD, University Hospital of Cologne, University of Cologne, Cologne, Germany; Helen Goergen, Dipl-Math, Michael Fuchs, MD, and Horst Müller, German Hodgkin Study Group, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany; Christan Baues, MD, University Hospital of Cologne, University of Cologne, Cologne, Germany; Andreas Engert, MD, German Hodgkin Study Group, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany; Markus Dietlein, MD, University Hospital of Cologne, University of Cologne, Cologne, Germany; and Bastian von Tresckow, MD and Peter Borchmann, MD, German Hodgkin Study Group, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2019 Dec 01; Vol. 37 (34), pp. 3324-3325. Date of Electronic Publication: 2019 Sep 30.